These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2192004)
1. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. Frenck RW; Sarman G; Harper TE; Buescher ES J Infect Dis; 1990 Jul; 162(1):109-14. PubMed ID: 2192004 [TBL] [Abstract][Full Text] [Related]
2. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3. Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice. Tanaka T; Okamura S; Okada K; Suga A; Shimono N; Ohhara N; Hirota Y; Sawae Y; Niho Y Infect Immun; 1989 Jun; 57(6):1792-9. PubMed ID: 2656523 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275 [TBL] [Abstract][Full Text] [Related]
5. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. Mayer P; Schütze E; Lam C; Kricek F; Liehl E J Infect Dis; 1991 Mar; 163(3):584-90. PubMed ID: 1995731 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023 [TBL] [Abstract][Full Text] [Related]
7. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC). Hofer M; Vacek A; Weiterová L Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Baldwin GC; Gasson JC; Quan SG; Fleischmann J; Weisbart R; Oette D; Mitsuyasu RT; Golde DW Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2763-6. PubMed ID: 3282238 [TBL] [Abstract][Full Text] [Related]
9. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow. Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Iguchi K; Inoue S; Kumar A Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109 [TBL] [Abstract][Full Text] [Related]
11. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. Neta R; Oppenheim JJ; Douches SD J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factors: biology and clinical application. Gabrilove JL; Jakubowski A J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284 [TBL] [Abstract][Full Text] [Related]
13. The promise of colony-stimulating factors in clinical practice. Glaspy JA; Ambersley JM Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043 [TBL] [Abstract][Full Text] [Related]
14. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967 [No Abstract] [Full Text] [Related]
15. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs. Mayer P; Werner FJ; Lam C; Besemer J Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance. Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361 [TBL] [Abstract][Full Text] [Related]
17. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor. Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial. Steis RG; VanderMolen LA; Longo DL; Clark JW; Smith JW; Kopp WC; Ruscetti FW; Creekmore SP; Elwood LJ; Hursey J J Natl Cancer Inst; 1990 Apr; 82(8):697-703. PubMed ID: 2138680 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development. Bonnem EM; Morstyn G Semin Oncol; 1988 Oct; 15(5 Suppl 5):46-51. PubMed ID: 3057644 [No Abstract] [Full Text] [Related]
20. Review of G-CSF and GM-CSF. Effects on neonatal neutrophil kinetics. Cairo MS Am J Pediatr Hematol Oncol; 1989; 11(2):238-44. PubMed ID: 2473663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]